Eijsvogel P, Misra P, Concha-Marambio L, Boyd JD, et al. Target engagement and immunogenicity of an active immunotherapeutic targeting pathological alpha-synuclein: a phase 1 placebo-controlled trial. Nat Med 2024;30:2631-2640.
PMID: 38902546